Carasent AB (publ) (LTS:0H9M) Total Long-Term Assets: kr853.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0H9M Carasent AB (publ) LTS:0H9M
73 GF Score
Price kr20.60
GF Value kr22.32
! 5 Warning Signs
View Full Analysis

What is Carasent AB (publ) Total Long-Term Assets?

Carasent AB (publ) LTS:0H9M 73 Total Long-Term Assets is kr853.0 Mil as of Jun. 2026. GuruFocus rates LTS:0H9M with a GF Score™ of 73/100 and a GF Value™ of kr22.32. The stock has 5 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Carasent AB (publ)'s Total Long-Term Assets for the quarter that ended in Jun. 2026 was kr853.0 Mil.

Carasent AB (publ) Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Carasent AB (publ)'s Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carasent AB (publ) Total Long-Term Assets Chart

Carasent AB (publ) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 396.70 641.22 679.16 772.03 786.80

Carasent AB (publ) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 775.99 780.18 786.80 752.94 853.02
LTS:0H9M
73GF Score
Carasent AB (publ) LTS:0H9M
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carasent AB (publ) Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of kr853.0 Mil mean?
Carasent AB (publ) (LTS:0H9M) has a Total Long-Term Assets of kr853.0 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Carasent AB (publ) and its competitors.
Is Carasent AB (publ)'s Total Long-Term Assets too high?
Carasent AB (publ)'s current Total Long-Term Assets is kr853.0 Mil. Overall, Carasent AB (publ) has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s Total Long-Term Assets compare to VEEV and BTSG?
Carasent AB (publ)'s Total Long-Term Assets of kr853.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Healthcare Providers & Services company?
A good Total Long-Term Assets depends on the Healthcare Providers & Services industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Carasent AB (publ) and its competitors. Carasent AB (publ)'s current Total Long-Term Assets is kr853.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Carasent AB (publ) (LTS:0H9M) has a current Total Long-Term Assets of kr853.0 Mil. The stock's GF Value™ is kr22.32, compared to a current price of kr20.60 — trading 7.7% below its estimated fair value. The current Total Long-Term Assets is kr853.0 Mil. Carasent AB (publ)'s overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Carasent AB (publ) (LTS:0H9M), the current Total Long-Term Assets is kr853.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carasent AB (publ) (LTS:0H9M) Overvalued in 2026?

Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued. The current stock price of kr20.60 is trading 7.7% below its estimated GF Value™ of kr22.32.

Key valuation signals for LTS:0H9M:

  • Total Long-Term Assets: kr853.0 Mil
  • GF Value™: kr22.32 vs. price of kr20.60 (7.7% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the LTS:0H9M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carasent AB (publ) Business Description

Other Exchanges CARA:SwedenE0C:Germany
Address Nellickevagen 24C, Gothenburg, NOR, 412 63
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
73GF Score

Get the complete analysis for LTS:0H9M

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.60
Price
kr22.32
GF Value